Mr. Chris White has been appointed as New President and Chief Financial Officer of Strams Biotech

Houston, TX, August 29, 2023 (PRNewswire) -- The Chief Executive Officer of Houston-based Biotechnology Company Stramsen Biotech Inc. Dr. Kefas Mugittu (Ph.D.) has announced 32 Drug candidates in company's pipeline at a company's board meeting. These are new natural plant-based medicine candidates that are in different stages. The company's Board Members' meeting took place on July 30, 2023.

Read full article here.